Eli Lilly (LLY) Other Non Operating Income (2009 - 2012)

Eli Lilly (LLY) posted Other Non Operating Income of -$26.8 million for Q1 2012, down 2336.36% quarter-over-quarter from -$1.1 million in Q4 2011, and down 240.31% year-on-year from $19.1 million in Q2 2011.

Eli Lilly (LLY) Other Non Operating Income (2009 - 2012) Analysis & Trends

Eli Lilly (LLY) has reported Other Non Operating Income for 4 consecutive years, with -$26.8 million the latest figure, recorded in Q1 2012.

  • Other Non Operating Income for Q1 2012 came in at -$26.8 million, down 240.31% year-over-year; the trailing twelve-month figure through Mar 2012 was -$118.8 million (down 428.18% YoY), and the FY2011 annual result was -$72.9 million, down 156.69% from the prior year.
  • Other Non Operating Income was -$26.8 million for Q1 2012 at Eli Lilly, down from -$1.1 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $111.5 million in Q1 2010 and troughed at -$205.1 million in Q4 2009.
  • Average Other Non Operating Income over 4 years is -$12.2 million, with a median of -$1.1 million recorded in 2011.
  • Year-over-year, Other Non Operating Income surged 257.71% in 2010 and sank 758.7% in 2011.
  • Over 4 years, Other Non Operating Income stood at -$205.1 million in 2009, then jumped by 95.03% to -$10.2 million in 2010, then surged by 89.22% to -$1.1 million in 2011, then tumbled by 2336.36% to -$26.8 million in 2012.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$26.8 million in Q1 2012, -$1.1 million in Q4 2011, and -$60.6 million in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2012 -26.80 Mn
Dec 31, 2011 -1.10 Mn
Sep 30, 2011 -60.60 Mn
Jun 30, 2011 -30.30 Mn
Mar 31, 2011 19.10 Mn
Dec 31, 2010 -10.20 Mn
Sep 30, 2010 9.20 Mn
Jun 30, 2010 18.10 Mn
Mar 31, 2010 111.50 Mn
Dec 31, 2009 -205.10 Mn
Sep 30, 2009 66.90 Mn
Jun 30, 2009 21.40 Mn
Mar 31, 2009 -70.70 Mn